Ehouse Global, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
21/100
20
Profitability
15
Growth
20
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EHOS research report →
52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00
Companywww.ehouseglobal.com
Ehouse Global, Inc. engages in the development, production, and sale of liquid supplements. It offers vitamins, minerals, sports nutrition supplements, diet, and wellness products.
- CEO
- Jonathan Smith
- IPO
- 2013
- Employees
- 2
- HQ
- San Diego, US
Price Chart
+900.00% · this period
Valuation
- Market Cap
- $10.13K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.52
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 408.74%
- ROIC
- 180.87%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-2,780,000 · -957.03%
- EPS
- $-0.61 · -125.93%
- Op Income
- $-1,218,000
- FCF YoY
- -247.72%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.38
- Avg Volume
- 2.51M
Get TickerSpark's AI analysis on EHOS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EHOS Coverage
We haven't published any research on EHOS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EHOS Report →Similar Companies
PBLA+0.00%
Panbela Therapeutics, Inc.
$0.00
HTDS+0.00%
Hard to Treat Diseases Inc.
$0.00
MOBO+0.00%
Mobile Lads Corp.
$0.00
BRAXF+0.00%
Braxia Scientific Corp.
$0.00
IRBS+0.00%
IR Biosciences Holdings Inc.
$0.00
NVOS+0.00%
Novo Integrated Sciences, Inc.
$0.00
GBLX+33.33%
GB Sciences, Inc.
$0.00
BBBT+0.00%
Black Bird Biotech, Inc.
$0.00